Down 29% from Oct 28 to Nov 6 while the S&P 500 fell 5%.
TXG's Quality Score fell 2 points on Fri, Nov 6, to 3.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | Moves 11.8% a day while sales shrink |
| Latest filing | 8-K, Nov 5 |
ReportThu Nov 5: sales of $150.7M; a loss of $0.15 a share. Raised its outlook for the year. Past reports ›
Thu Nov 510x Genomics Reports Third Quarter 2026 Financial Results
Tue Nov 17: Jefferies 17th Annual London Global…Investor conference · date confirmed.
After its last 4 reports it closed +4.0% on average, higher 3 of 4 times.
Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
TXG is #11 of 15 by Quality Score among Laboratory Analytical Instruments.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| 11 |
Share count against a year before: TXG +5%, ILMN -3.8%, MTD -2.7%, BIO -1.8%.
Expected to report Thu Feb 11, after the close (in 96 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $150.7M, 1% more than a year ago; a loss of $0.15 a share, from $0.22.
“The increase in gross margin was primarily due to lower inventory write-downs and changes in product mix.”
TXG's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Revenue | $625M to $635M |
“The decrease was primarily driven by lower personnel and lab equipment expenses, partially offset by higher litigation expenses.”
From its results filing (SEC filing · Nov 5)
Sales grew 17% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 4.3% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Nov 5, 2026 | -0.3% | +2.1% | open |
| Aug 6, 2026 | -0.2% | +14.1% | +27.5% |
| May 7, 2026 | -6.0% | -3.7% | -4.0% |
Sales grew in six of the last seven years, to $643M in 2025. It lost money in each of the eight years.
4 insiders sold $6.2M across 10 filings in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: TXG is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
“The life sciences industry is highly competitive.”
TXG scores 3 today, which Breakaway calls Below Average. It is #11 of 15 in Laboratory Analytical Instruments by Quality Score, with 2 of 14 chart checks firing. Down 29% from Oct 28 to Nov 6 while the S&P 500 fell 5%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
TXG scores 3 today, which Breakaway calls Below Average (0 to 5). That is #11 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TXG's 3.
4 insiders sold $6.2M across 10 filings in the last 6 months. No open-market buys on record. The newest is John R. Stuelpnagel, Director, who sold $425K on Sep 3. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.